# Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-correlative-biomarkers-of-toripalimab-in-previously-treated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Feng‐Hua Wang,Xiaoli Wei,Jifeng Feng,Qi Li,Nong Xu,Xichun Hu,Wangjun Liao,Yi Jiang,Xiaoyan Lin,Qingyuan Zhang,Xianglin Yuan,Haixin Huang,Ye Chen,Guanghai Dai,Jianhua Shi,Lin Shen,Shujun Yang,Yongqian Shu,Yunpeng Liu,Weifeng Wang,Hai Wu,Hui Feng,Sheng Yao,Rui‐Hua Xu |
| Citations | 360 |
| DOI | 10.1200/jco.20.02712 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.02712 |
| OpenAlex ID | https://openalex.org/W3124559501 |
| PMID | 33492986 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Ye Chen](https://scholariq.org/researchers/ye-chen/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

## Paper topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.